Danaher is poised for more gains

Article Excerpt

DANAHER CORP. $266 is a buy for aggressive investors. The company (New York symbol DHR; Aggressive Growth Portfolio; Manufacturing sector; Shares outstanding 722.2 million; Market cap: $192.1 billion; Price-to-sales ratio: 8.4; Dividend yield: 0.4%; TSINetwork Rating: Above Average; www.danaher.com) makes precision-testing equipment and tools for medical research labs and municipal water utilities. In the three months ended June 28, 2024, Danaher’s revenue fell 2.9%, to $5.74 billion from $5.91 billion a year earlier. That decline was largely because customers are delaying new orders as they use up their current inventories. Earnings per share slipped 0.6%, to $1.72 from $1.73, but still beat the consensus estimate of $1.57. For all of 2024, earnings will likely rise 0.1% to $7.59 a share. The stock, which is up 14% since the start of the year, trades a high, but still reasonable, 35.0 times that estimate. The $1.08 dividend yields 0.4%. Danaher is a buy for aggressive investors. investors…